Allison J. Schaser

Allison J. Schaser

Auto-generated profile, based on publicly available information

Allison J. Schaser

Department of Speech, Language, and Hearing Sciences, Purdue University, West Lafayette, Indiana, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ASAllison J. Schaser
Allison J. Schaser
VOValerie R. Osterberg
Valerie R. Osterberg
SDSydney E. Dent
Sydney E. Dent
TSTeresa L. Stackhouse
Teresa L. Stackhouse
CWColin M. Wakeham
Colin M. Wakeham
VUVivek Unni
Vivek Unni
Alpha-synuclein is a presynaptic protein that forms abnormal cytoplasmic aggregates in Lewy body disorders. Although nuclear alpha-synuclein localization has been described, its function in the nucleus is not well understood. We demonstrate that alpha-synuclein modulates DNA repair. First, alpha-synuclein colocalizes with DNA damage response components within discrete foci in human cells and mouse brain. Removal of alpha-synuclein in human cells leads to increased DNA double-strand break (DSB) levels after bleomycin treatment and a reduced ability to repair these DSBs. Similarly, alpha-synuclein knock-out mice show increased neuronal DSBs that can be rescued by transgenic reintroduction of human alpha-synuclein. Alpha-synuclein binds double-stranded DNA and helps to facilitate the non-homologous end-joining reaction. Using a new, in vivo imaging approach that we developed, we find that serine-129-phosphorylated alpha-synuclein is rapidly recruited to DNA damage sites in living mouse cortex. We find that Lewy inclusion-containing neurons in both mouse model and human-derived patient tissue demonstrate increased DSB levels. Based on these data, we propose a model whereby cytoplasmic aggregation of alpha-synuclein reduces its nuclear levels, increases DSBs, and may contribute to programmed cell death via nuclear loss-of-function. This model could inform development of new treatments for Lewy body disorders by targeting alpha-synuclein-mediated DNA repair mechanisms.

1 September 2011 in Behavioural Brain Research
Verified
Journal Article
Closed access
MCMichelle R. Ciucci
Michelle R. Ciucci
JRJohn A. Russell
John A. Russell
ASAllison J. Schaser
Allison J. Schaser
EDEmerald J. Doll
Emerald J. Doll
LVLisa M. Vinney
Lisa M. Vinney
NCNadine P. Connor
Nadine P. Connor

31 August 2010 in Dysphagia
Verified
Journal Article
Closed access
PDF file
ASAllison J. Schaser
Allison J. Schaser
HWHao Wang
Hao Wang
LVLana M. Volz
Lana M. Volz
NCNadine P. Connor
Nadine P. Connor

21 November 2012 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
NCNadine P. Connor
Nadine P. Connor
JRJohn A. Russell
John A. Russell
MJMichelle A. Jackson
Michelle A. Jackson
HKHeidi Kletzien
Heidi Kletzien
HWHao Wang
Hao Wang
DZDavid L. Zealear
David L. Zealear

1 January 2012 in Behavioural Brain Research
Verified
Journal Article
Closed access
ASAllison J. Schaser
Allison J. Schaser
KSKyle Stang
Kyle Stang
NCNadine P. Connor
Nadine P. Connor
MBMary Behan
Mary Behan

27 July 2024 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
RMRodrigo Mohallem
Rodrigo Mohallem
ASAllison J. Schaser
Allison J. Schaser
Uma AryalUma Aryal
Uma Aryal
A central hallmark of neurodegenerative diseases is the irreversible accumulation of misfolded proteins in the brain by aberrant phosphorylation. Understanding the mechanisms underlying protein phosphorylation and its role in pathological protein aggregation within the context of aging is crucial for developing therapeutic strategies aimed at preventing or reversing such diseases. Here, we applied multi-protease digestion and quantitative mass spectrometry to compare and characterize dysregulated proteins and phosphosites in the mouse brain proteome using three different age groups: young-adult (3-4 months), middle-age (10 months), and old mice (19-21 months). Proteins associated with senescence, neurodegeneration, inflammation, cell cycle regulation, the p53 hallmark pathway, and cytokine signaling showed significant age-dependent changes in abundances and level of phosphorylation. Several proteins implicated in Alzheimer's disease (AD) and Parkinson's disease (PD) including tau (Mapt), Nefh, and Dpysl2 (also known as Crmp2) were hyperphosphorylated in old mice brain suggesting their susceptibility to the diseases. Cdk5 and Gsk3b, which are known to phosphorylate Dpysl2 at multiple specific sites, had also increased phosphorylation levels in old mice suggesting a potential crosstalk between them to contribute to AD. Hapln2, which promotes α-synuclein aggregation in patients with PD, was one of the proteins with highest abundance in old mice. CD9, which regulates senescence through the PI3K-AKT-mTOR-p53 signaling was upregulated in old mice and its regulation was correlated with the activation of phosphorylated AKT1. Overall, the findings identify a significant association between aging and the dysregulation of proteins involved in various pathways linked to neurodegenerative diseases with potential therapeutic implications.